抗体治疗

The weeklong Antibody Therapeutics pipeline reveals the exciting developments in next-generation antibody therapeutics, including Antibody-Drug Conjugates, Bispecific Antibody Therapeutics, and Cancer Immunotherapies. Along with engineering breakthroughs, this pipeline also explores successful R&D strategies, translational case studies, clinical results, and efficacy data for these promising molecules as they seek to conquer cancer and other diseases and promote human health.


1月20~21日

Engineering Next-Generation Cancer Immunotherapies
( 次世代癌症免疫疗法的开发 )

1月21~22日

Antibody-Drug Conjugates
( 抗体药物复合体 )

1月23~24日

Bispecific Antibody Therapeutics
( 双特异性抗体疗法 )


Keynote Speakers

Shahram Salek-Ardakani, PhD, Senior Director, Cancer Immunology Discovery, Pfizer


Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC


Partha S. Chowdhury, Senior Director, Biologics Research, Sanofi Genzyme


* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English






2020年会议节目和培训研讨会


免费电子邮件通知服务